@Zenox I wonder, whether somewhere on the board, any one picked up any research on the mechanism of action of monoclonal antibodies to fight COVID?
There seems to some chatter in the government about this consortium pushing to investigate using monoclonal antibodies to fight covid-19.
In my limited understanding, MAs mimic the body's immune response, but it seems to me that its yet to solve the 'cytokine storm' part, which is the most concerning part of the covid complications.
Thoughts?
Cell Therapy News/Articles, page-5978
-
- There are more pages in this discussion • 11,847 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.26 |
Change
-0.050(3.83%) |
Mkt cap ! $1.432B | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.30 | $1.17 | $19.99M | 16.15M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 36 | 267137 | $1.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.26 | 4011 | 8 |
View Market Depth
| Last trade - 15.53pm 24/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |